CPRX - Catalyst Pharmaceuticals beats by $0.07 beats on revenue May, 13 2019 06:04 AM Catalyst Pharmaceuticals Inc. Catalyst Pharmaceuticals (NASDAQ:CPRX): Q1 GAAP EPS of -$0.01 beats by $0.07.More news on: Catalyst Pharmaceuticals, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...